Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
Completed · Phase 2
Conditions studied: Prostate Cancer
In brief
The purpose of this phase 2, open-label, single-arm, multidose, multicenter study is to investigate the effects of Orteronel plus Prednisone on the QT/QTc interval in patients with Metastatic Castration-Resistant Prostrate Cancer
Key facts
- Study ID
- NCT01549951
- Run by
- Millennium Pharmaceuticals, Inc.
- People needed
- 50
- Starts
- 2012-05-01
- Expected to finish
- 2015-01-01
- Last updated by the study team
- 2016-06-01
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Voluntary written consent
- Screening PSA ≥ 2ng/ml
- Patients must have a diagnosis of mCRPC
- Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1
- Prior surgical or medical castration with testosterone at screening < 50 ng/dL
You may not qualify if…
- Prior chemotherapy for prostate cancer within 6 months prior to screening. (Any prior therapy with cabazitaxel, mitoxantrone, or anthracyclines is exclusionary.)
- Documented central nervous system metastases
- Clinically significant heart disease
- Patients who have an abnormal 12-lead ECG result at screening including one or more of the following: QRS>110 ms, QTcF>480ms, PR interval>200 ms
- Patients who have a history of risk factors for TdP including unexplained syncope, known long QT syndrome, heart failure, angina, or clinically significant abnormal laboratory assessments
- Please note that there are additional inclusion and exclusion criteria. The study center will determine if you meet all of the criteria.
- Site personnel will explain the trial in detail and answer any question you may have if you do qualify for the study. You can then decide whether or not you wish to participate. If you do not qualify for the trial, site personnel will explain the reasons
Where it is running
- Pinnacle Oncology — Scottsdale, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.